Member Info for Ejackson

I thought similar to you QD22.
They have identified the issue and put in place the remedy focusing on and rolling out what works:

o The Group completed restructuring of the operational and commercial activities for the dCELL® division which will provide an opportunity to increase new customer wins as well as increased penetration and upsell of existing accounts.

· Expansion of product portfolio and additional product line extensions:

o During the year the Group successfully launched product line extensions in its dCELL® division; DermaPure® Meshed, VNEW™ and MatrixND™.

It is very encouraging to see the progress he has made over the past year.
A very solid RNS and we are in an excellent position now to grow strongly for 2022.
I would like to see some more distribution agreements being signed so as to gain greater market penetration.

Not the sort of RNS to calm investors in these uncertain times.
A buying opportunity though given the guidance reiterating FY expectations and how 2022 has started. By way of reassurance, SMS is a finance man through and through so he will be comfortable with what he has seen and no doubt will have sat down with Mary Basterfield to discuss all the finer detail easing her into the FD position.
PWC need to get a grip and if they can’t keep pace with the pace of mergers and are happy to blame COVID and travel restrictions, we need to look elsewhere. Poor.

https://www.reuters.com/business/martin-sorrell-considers-new-york-listing-s4-capital-times-2022-02-20/
I am pleased to see SMS is taking another look at listing in NY. I would also conclude that he would only have made this statement from a position of strength, namely that FY 21 figures due in March will be excellent and current trading is strong and in line, if not ahead of market guidance.
SMS has stated very clearly that he is focused on top line growth and whilst this is currently unpopular with the market, the SP will not reflect the true direction S4 is headed.
I have ‘followed the money’ and increased my investment at a similar time to SMS and Scott Spirit. They are in the know and will ensure the SP ultimately reflects their proven strategy. The market will not be able to ignore it and I am sure all those that ‘merged’ will be wanting to see the same as they too have significant skin in the game.
One last thought is that whilst valuations are low, SMS must feel frustrated that he is hamstrung in being able to pursue some large and attractive ‘mergers’ which might be ultimately why he likes the NY listing as raising funds there with the assistance of Daniel Pinto, who is now based in the US, could prove more simple.

I agree 100% Pokerchips.
Today has been a a confirmatory update that we are heading in the right direction and as elective surgery becomes more commonplace, we will benefit accordingly. There is a huge backlog to support the growth narrative, I only hope there are enough surgeons to meet the demand.
Growth in revenue given the COVID backdrop is pleasing. They have put the ‘wet room’ side in a place ready to facilitate forward demand and taken the right steps on cost reduction.
Cash burn looks under control so we have a solid platform to grow revenue and profit quickly from here notwithstanding an outbreak of new COVID strain.
The SP growth suggested also looks realistic as the numbers come through and I would encourage the Board to update us accordingly.

We are caught up in the Tech related sell off.
S4’s fundamentals remain solid given companies move to digital advertising and the projections for significant growth in the coming years. As such, I look forward to the next TU which should reassure investors.
In the meantime, the SP will get put through the mangle all the while Tech is unfashionable and we concentrate on top line growth and less so EBITDA which the market likes to use as a preferred method of valuation.
Time for tin hats if you are following the SP daily or a good brandy and come back after the first quarter results if more long term orientated. I am in the latter.

https://www.campaignlive.co.uk/article/goodstuff-founders-sell-agency-us-challenger-group-stagwell/1736512

This might have something to do with the 10% drop. I would imagine SMS was involved but ultimately didn’t entice them over to S4. It will hurt.
Interesting to note Penn at Stagwell was ex WPP and has created a very similar company to S4 with almost identical ambitions. I wonder how they get along with each other?
All this aside, a 10% drop is a concern and the slide from the mid £8 and being well below the 200 day moving average of c£6.40 doesn’t bode well right now.
A TU as provided this time last year would offer some clarity either way.

SMS is fond of knocking WPP and regularly stating how much value has been lost since he left however, a quick look to compare the two SP’s over the past 6 months and a year respectively is revealing:
S4 -10% & +20%
WPP +15% & +43%
As a close watcher of such things, it won’t be lost on him and whilst he has maintained his substantial shareholding in WPP and benefitted accordingly, many that have come on board with their equity stakes in S4 have now not. This will probably not sit comfortably with a number of senior personnel.
When everything is heading in the right direction, the negative noise is minimal but I suspect there are a growing number that are concerned at the current direction of the SP and will want him to address this as a priority or merger targets and staff retention may prove to be more challenging.

I could not agree any more P100. My sentiments entirely.
I would only add that the market has seemingly been ahead of the news on every occasion.

This is possibly the most important and positive RNS that I can recall for a number of years.
We are finally on the cusp to monetising our product.
Pressing against the finishing tape comes to mind, a couple more steps and we will be there.

Thank you. I will take a look.

We close above £3.00.
A quick look at the shares traded suggests a batch of sell orders going through and we have been rewarded with a 5% uplift.
Are we witnessing Frasers selling down and increasing liquidity? Who knows but if the market is sending a message to MA that if he does something meaningful then the SP will respond accordingly.
Not too long to wait to hear what the final numbers were for last year and of more importance, what is contained in the Capital Markets Day.

So, AB must have liked his telcon with MA enough to top up.
My sense is that we will know more after the presentation and results at the end of June. Disappointing that we have to wait so long but it could herald a new dawn.
I am looking for guidance on dividends as we are now cash generative and given the projections on revenue (PK repeatedly has referenced £1bn as his target) and what we could reasonably expect this to translate to earnings, we could be looking at a very low future single digit P/E at today’s valuation.
It appears to me that this very basic assumption is not lost on AB / Schroders and given the level of contact he will have had with senior management of late, he has turned buyer again.
I am pleased my hunch to top up a month or so ago when the SP was a bit lower has been endorsed and notwithstanding the above, we could still see MA make a move per my previous view. If I had his resources, I would definitely be looking to take control, give the management some ‘skin’ to reward them further down the line and reap the reward on a significant multiple when the company realists. MA doesn’t like to sit on the share register without an exit strategy normally because it’s a distressed asset. , He always ultimately wants control and the only thing that seems to have worked against him here is that STU has actually turned the business around and become very profitable albeit with the assistance of COVID.
An interesting conundrum for him to have but I can only see it ultimately working to our advantage.

Come on Skindle, you know better than that.
If Schroders are so much in Frasers/ MA’s pocket, he would have backed his previous mandatory takeover.
I am cross at how things are currently but we need to keep some perspective until we know the next development which is likely to be either an offer from MA per my previous viewpoint or following the presentation from the Board in June.

Looking at how a Director purchase of 6,500 reduces our SP by approaching 2%, can you imagine what would happen if MA sold down to below 30%.
AB make the call please.....!

Good to see another Director buying today.
When will the market agree with the confidence being shown by the people in the know and move the share price accordingly.
Perversely, every time a Director has bought recently, the share price has fallen.

A very impressive set of numbers and having watched the presentation, there is clearly a lot more to come.
Hard not be anything other than bullish here.

Once again, good to see the buying activity today and the SP going south accordingly.

https://www.cityam.com/martin-sorrell-blasts-petty-wpp-after-share-awards-cut-over-leak-claims/

If anything is guaranteed to drive MS forward, this is it.
I only hope he doesn’t get too embroiled in a verbal spat and just lets his lawyers get on with it and in the meantime goes turbocharged on S4’s continued growth and achieve his desire to overtake WPP’s valuation.
Revenge is a dish best served cold. Stay calm Martin and hit them where it really hurts, they are clearly rattled.

Good to see some topping up from the two Directors that know the most.
Equally good to see some reasonable buy trades go through notably outweighing the sells and that the market responded positively......you couldn’t make it up.